The main objective of this application is to examine the role of tumor physiology in the therapeutic response of solid tumors to hyperthermia. In specific, the following interactions will be examined. a) The relationship between pretreatment tumor physiologic status and therapeutic response to heat. b) The effect of thermal sensitivity modulators (i.e., hyperglycemia or flavone acetic acid) on pretreatment tumor physiologic status and the effect of those changes on therapeutic response to heat. c) The effect of heat on tumor physiological status both during and after heating and the effect of the heat induced modulation of such metabolic status on therapeutic response. These complex interactions between tumor physiological status and therapeutic response. These complex interactions between tumor physiological status and therapeutic response to hyperthermia will be examined in a set of parallel in situ/in vitro experiments. In the in situ experiments, the pretreatment tumor physiological status and its dynamic response to thermal sensitizers and hyperthermia (at 41 degrees C, 43 degrees, or 45 degrees C) and the relationship of that physiological status to therapeutic response will be examined with multinuclear in vivo NMR spectroscopy; (i.e., 31P NMR will be used to measure tumor pH and the concentrations of ATP, PCr and Pi; 1H NMR will be used to measure tumor lactate concentration; and a 2H NMR technique recently developed and validated in the PI's laboratory will be used to measure tumor blood flow.) In a parallel set of in vitro experiments, the interrelated physiological variables will be independently controlled in an in vitro perfusion apparatus which allows the physiologic status of the cells to be monitored continuously and noninvasively with 31P and 1H NMR. Because these interactions may have an impact on the optimum sequencing and timing of hyperthermia when used as an adjuvant to either radiotherapy or chemotherapy and NMR spectroscopy can be used to examine human tumors, the results of these laboratory investigations should provide a framework for the implementation of NMR spectroscopy to aid in the clinical application of hyperthermia alone and in conjunction with other modalities of therapy.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Radiation Study Section (RAD)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Washington University
Schools of Arts and Sciences
Saint Louis
United States
Zip Code
Spees, William M; Evelhoch, Jeffrey L; Thompson, Paul A et al. (2005) Defining the pHi-hyperthermia sensitivity relationship for the RIF-1 tumor in vivo: a 31P MR spectroscopy study. Radiat Res 164:86-99
Bezabeh, T; Evelhoch, J L; Sloop, D J et al. (2004) Methodology for applied 4 MHz RF hyperthermia concomitant with 31P NMR spectroscopic monitoring of murine tumours. Int J Hyperthermia 20:637-45
Bezabeh, T; Evelhoch, J L; Thompson, P et al. (2004) Therapeutic efficacy as predicted by quantitative assessment of murine RIF-1 tumour pH and phosphorous metabolite response during hyperthermia: an in vivo 31P NMR study. Int J Hyperthermia 20:335-57
Soto, G E; Zhu, Z; Evelhoch, J L et al. (1996) Tumor 31P NMR pH measurements in vivo: a comparison of inorganic phosphate and intracellular 2-deoxyglucose-6-phosphate as pHnmr indicators in murine radiation-induced fibrosarcoma-1. Magn Reson Med 36:698-704
Ackerman, J J; Soto, G E; Spees, W M et al. (1996) The NMR chemical shift pH measurement revisited: analysis of error and modeling of a pH dependent reference. Magn Reson Med 36:674-83
Evelhoch, J L (1992) Measurement of tumor blood flow by deuterium NMR and the effects of modifiers. NMR Biomed 5:290-5
Hwang, Y Y; Kim, S G; Evelhoch, J L et al. (1992) Nonglycolytic acidification of murine radiation-induced fibrosarcoma 1 tumor via 3-O-methyl-D-glucose monitored by 1H, 2H, 13C, and 31P nuclear magnetic resonance spectroscopy. Cancer Res 52:1259-66
Neil, J J; Song, S K; Ackerman, J J (1992) Concurrent quantification of tissue metabolism and blood flow via 2H/31P NMR in vivo. II. Validation of the deuterium NMR washout method for measuring organ perfusion. Magn Reson Med 25:56-66
Bezabeh, T; Ackerman, J J (1992) Chemical exchange in tissue extracts revisited: bicarbonate and deuterium isotope effects on 31P resonances of phosphoethanolamine and phosphocreatine. NMR Biomed 5:364-7
Mattiello, J; Evelhoch, J L (1991) Relative volume-average murine tumor blood flow measurement via deuterium nuclear magnetic resonance spectroscopy. Magn Reson Med 18:320-34

Showing the most recent 10 out of 18 publications